Zobrazeno 1 - 10
of 185
pro vyhledávání: '"Olov Wiklund"'
Autor:
Francois Mach, Colin Baigent, Alberico L. Catapano, Konstantinos C. Koskinas, Manuela Casula, Lina Badimon, M. John Chapman, Guy G. De Backer, Victoria Delgado, Brian A. Ference, Ian M. Graham, Alison Halliday, Ulf Landmesser, Borislava Mihaylova, Terje R. Pedersen, Gabriele Riccardi, Dimitrios J. Richter, Marc S. Sabatine, Marja-Riitta Taskinen, Lale Tokgozoglu, Olov Wiklund
Publikováno v:
Российский кардиологический журнал, Vol 25, Iss 5 (2020)
The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)
Externí odkaz:
https://doaj.org/article/85da4c90ec0e40e594dfee9db7ef0e09
Autor:
Alberico L. Catapano, Ian Graham, Guy De Backer, Olov Wiklund, John M. Chapman, Heinz Drexel, Arno V. Hoes, Catriona S. Jennings, Ulf Landmesser, Terje R. Pedersen, Željko Reiner, Gabriele Riccardi, Marja-Riitta Taskinen, Lale Tokgozoglu, W. M. Monique Verschuren, Charalambos Vlachopoulos, David A. Wood, Jose Luis Zamorano, Marie-Therese Cooney
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 5, Pp 7-77 (2017)
The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)Developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitat
Externí odkaz:
https://doaj.org/article/fb488d98750648749907f6ed2dab6d1d
Autor:
Zeljko Reiner, Alberico L. Catapano, Guy De Backer, Ian Graham, Marja-Riitta Taskinen, Olov Wiklund, Stefan Agewall, Eduardo Alegria, M. John Chapman, Paul Durrington, Serap Erdine, Julian Halcox, Richard Hobbs, John Kjekshus, Pasquale Perrone Filardi, Gabriele Riccardi, Robert F . Storey, David Wood
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 8, Iss 1, Pp 3-60 (2016)
Externí odkaz:
https://doaj.org/article/0b270ebea48344159542b2b8023db0dc
Publikováno v:
Vascular Health and Risk Management, Vol Volume 3, Pp 491-502 (2007)
Sven-Olof Olofsson, Olov Wiklund, Jan BorénSahlgrenska Center for Cardiovascular and Metabolic Research, the Wallenberg Laboratory University of GöteborgAbstract: Apolipoprotein (apo) AI and apoB are the major apolipoproteins of high-density lipopr
Externí odkaz:
https://doaj.org/article/94ec4ee785ea470982619c7cdd6e70e2
Autor:
Lisa U Magnusson, Annika Lundqvist, Merja Nurkkala Karlsson, Kristina Skålén, Max Levin, Olov Wiklund, Jan Borén, Lillemor Mattsson Hultén
Publikováno v:
PLoS ONE, Vol 7, Iss 8, p e43142 (2012)
Inflammation in the vascular wall is important for development of atherosclerosis. We have shown previously that arachidonate 15-lipoxygenase type B (ALOX15B) is more highly expressed in human atherosclerotic lesions than in healthy arteries. This en
Externí odkaz:
https://doaj.org/article/22e10b26dc284395a89eeeca6e8a5ad2
Publikováno v:
Journal of Lipid Research, Vol 53, Iss 10, Pp 2015-2016 (2012)
Externí odkaz:
https://doaj.org/article/3c355b6b8f2f474b82e14e0d7d78e787
Autor:
Olov Wiklund, Göran Bondjers
Publikováno v:
Atherosclerosis.
Autor:
Ana F. Pina, Giovanni Volpe, Luca Valenti, Saga Helgadottir, Carlo Pirazzi, M. Paula Macedo, Tiziana Montalcini, Roberto Henriques, Rosellina Margherita Mancina, Olov Wiklund, Chiara Pavanello, Laura Calabresi, Stefano Romeo
Publikováno v:
European Journal of Preventive Cardiology. 27:1639-1646
Aims Familial hypercholesterolemia (FH) is the most common genetic disorder of lipid metabolism. The gold standard for FH diagnosis is genetic testing, available, however, only in selected university hospitals. Clinical scores – for example, the Du
Autor:
Yi Qian, Michal Vrablík, Alberico L. Catapano, Olov Wiklund, Mona L. Martin, Pratik P. Rane, Alyson Grove
Publikováno v:
Advances in Therapy
Introduction Statin intolerance (SI) occurs in patients with dyslipidemia treated with statins. Statin-associated symptoms have been reported, but the overall patient experience is poorly understood. No instruments are available to collect this patie
Publikováno v:
European Heart Journal. 42
Background and aims Statins are the standard of care for patients with dyslipidemia, but some patients develop intolerance to treatment. The experience of statin intolerant (SI) patients is poorly understood. The objective of this study was to identi